Association of p22phox gene C242T polymorphism with coronary artery disease: A meta-analysis

Thrombosis Research

Volumn 125, Issue 5, 2010, Pages

  Fang, Shengxia ^a   Wang, Lili ^a   Jia, Chongqi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Coronary artery disease; Gene polymorphism; Meta analysis; NADPH oxidase; p22phox

Indexed keywords

PROTEIN P22PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CODOMINANCE; CORONARY ARTERY DISEASE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; RECESSIVE INHERITANCE;

CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NADPH OXIDASE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 77951666823     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.01.001     Document Type: Article

References (23)

1. Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129-142
2. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., and Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271 (1996) 23317-23321
3. Soccio M., Toniato E., Evangelista V., Carluccio M., and De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35 (2005) 305-314
4. Wyche K.E., Wang S.S., Griendling K.K., Dikalov S.I., Austin H., Rao S., et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43 (2004) 1246-1251
5. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., and Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97 (1998) 135-137
6. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
7. Harbord R.M., Egger M., and Sterne J.A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25 (2006) 3443-3457
8. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 47 (1999) 15-17
9. Cai H., Duarte N., Wilcken D.E., and Wang X.L. NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 29 (1999) 744-748
10. Gardemann A., Mages P., Katz N., Tillmanns H., and Haberbosch W. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145 (1999) 315-323
11. Li A., Prasad A., Mincemoyer R., Satorius C., Epstein N., Finkel T., et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 86 (1999) 57-61
12. Saha N., Sanghera D.K., and Kamboh M.I. The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 29 (1999) 999-1002
13. Lee W.H., Hwang T.H., Oh G.T., Kwon S.U., Choi Y.H., and Park J.E. Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males. Vasc Med 6 (2001) 103-108
14. Stanger O., Renner W., Khoschsorur G., Rigler B., and Wascher T.C. NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin Physiol 21 (2001) 718-722
15. Yamada Y., Izawa H., Ichihara S., Takatsu F., Ishihara H., Hirayama H., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
16. Mata-Balaguer T., de la Herran R., Ruiz-Rejon C., Ruiz-Rejon M., Garrido-Ramos M.A., and Ruiz-Rejon F. Angiotensin-converting enzyme and p22(phox) polymorphisms and the risk of coronary heart disease in a low-risk Spanish population. Int J Cardiol 95 (2004) 145-151
17. Fan M., Kahonen M., Rontu R., Lehtinen R., Viik J., Niemi M., et al. The p22phox C242T gene polymorphism is associated with a reduced risk of angiographically verified coronary artery disease in a high-risk Finnish Caucasian population. The Finnish Cardiovascular Study. Am Heart J 152 (2006) 538-542
18. Nasti S., Spallarossa P., Altieri P., Garibaldi S., Fabbi P., Polito L., et al. C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Markers 22 (2006) 167-173
19. He M.A., Cheng L.X., Jiang C.Z., Zeng H.S., Wang J., Wang F., et al. Associations of polymorphism of P22(phox) C242T, plasma levels of vitamin E, and smoking with coronary heart disease in China. Am Heart J 153 640 (2007) e1-e6
20. Niemiec P., Zak I., and Wita K. The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 18 (2007) 339-346
21. Vasiliadou C., Tousoulis D., Antoniades C., Marinou K., Tentolouris C., Koumallos N., et al. Genetic polymorphism C242T on the p22-phox subunit of NADPH oxidase, as a risk factor for myocardial infarction: Effects on platelets activation and oxidized LDL levels. J Am Coll Cardiol 49 (2007) 339A-340A
22. Macias-Reyes A., Rodriguez-Esparragon F., Caballero-Hidalgo A., Hernandez-Trujillo Y., Medina A., and Rodriguez-Perez J.C. Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radic Res 42 (2008) 82-92
23. Di Castelnuovo A., Soccio M., Iacoviello L., Evangelista V., Consoli A., Vanuzzo D., et al. The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb Haemost 99 (2008) 594-601